| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919069 | Radiotherapy and Oncology | 2012 | 9 Pages |
Abstract
Adjuvant androgen suppression, bisphosphonates and increasing EBRT dose did not increase rectal or urinary dysfunction in this trial. However dose escalation using HDRB increased urinary dysfunction.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
James W. Denham, Chantelle Wilcox, David S. Lamb, Nigel A. Spry, Gillian Duchesne, Chris Atkinson, John Matthews, Sandra Turner, Lizbeth Kenny, Keen-Hun Tai, Nirdosh Kumar Gogna, Martin Ebert, Brett Delahunt, Patrick McElduff, David Joseph,